sponsored content
December 16, 2024
Recently discovered findings continue emerging from the PROTECT RCT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) being conducted by Visioneering Technologies, Inc. to determine NaturalVue’s effect controlling myopia progression. VTI’s Chief Medical Officer Dr. Ashley Tuan shared them in this video recorded at the recent American Academy of Optometry in Indianapolis.
Watch the video to discover:
- How patient-reported outcomes for those wearing the treatment lens compare with those in the control lens.
- If and how pupil size as a covariant impacts the treatment effect.
- The difference between unadjusted and adjusted treatment effects on both myopia progression and axial length elongation and how the NaturalVue Multifocal performs after adjustment.
- Other exploratory data such as accommodative accuracy.
